Discover Glo: Bioluminescent Cell-Based Assay Seminar Tour – Edinburgh
Celebrating the launch of NanoLuc®, the most exciting new luciferase – and featuring presentations by leaders in the cellular analysis field, plus updates on the most recent products and technologies for cellular analysis from Promega.
- The George Hotel in Edinburgh. See map
- Date: Wednesday, March 6, 2013
- Time: 9:30 AM - 4:15 PM
Contact: hilary.latham@promega.com
Bioluminescent Cell-Based Assay Seminar Tour – Edinburgh Event
The Agenda:
| 09.30 - 10.00 |
Arrival, register (entry into the prize draw) & coffee |
| 10.00 - 10.10 |
Welcome Address
Matt Cook (Head of Commercial Sales, Promega UK)
|
| 10.10 - 11.00 |
NanoLuc® Luciferase: A Smaller, Brighter & More Versatile Luciferase Reporter
Dr Terry Riss, Promega Corporation, Madison
Abstract and Biography »
|
| 11.00 - 11.45 |
Development of Cell-Based Assays to Investigate Modulators of SIRT1 Activity
Dr Vad Lazari, BioFocus
Abstract and Biography »
|
| 11.45 - 12.10 |
Coffee |
| 12.10 - 13.00 |
Generating Metabolically Active Hepatocytes From Pluripotent Stem Cells
Dr David Hay, Principal Investigator, MRC Centre for Regenerative Medicine, University of Edinburgh
Abstract and Biography »
|
| 13.00 - 14.00 |
Lunch |
| 14.00 - 14.45 |
A Novel Cell-Based Screening Approach for the Identification of FOXA1 Pathway Inhibitors for the Treatment of Tamoxifen-Resistant Breast Cancer
Dr Aurore Lejeune, Cancer Research Technology, London
Abstract and Biography »
|
| 14.45 - 15.10 |
The LIMD1 Protein Bridges an Association between the Prolyl Hydroxylases and VHL to Repress HIF1 Activity
Dr Daniel Foxler, Barts Cancer Centre
Abstract and Biography »
|
| 15.10 - 15.50 |
Cell-Based Assays to Detect the Mechanism of Toxicity
Dr Terry Riss, Promega Corporation, Madison
Abstract and Biography »
|
| 15.50 - 16.15 |
Wrap up, coffee and prize draw for iPad Mini |